Share Price and Basic Stock Data
Last Updated: December 17, 2025, 10:30 pm
| PEG Ratio | 2.89 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vishnu Chemicals Ltd, operating in the inorganic chemicals sector, has demonstrated resilience in its revenue generation, with reported sales reaching ₹1,391 Cr in FY 2023. This figure reflects a notable increase from ₹1,069 Cr in FY 2022, highlighting a robust growth trajectory over the past year. However, the company has faced some headwinds in recent quarters, with sales dipping to ₹300 Cr in Q4 FY 2024, followed by a slight recovery to ₹339 Cr in Q1 FY 2025. The fluctuation in quarterly sales might raise concerns about demand stability. Nevertheless, the overall revenue for the trailing twelve months stands at ₹1,455 Cr, which underscores a growing trend despite recent quarterly volatility. The company’s ability to maintain a diverse product portfolio could be a strategic advantage in navigating these market fluctuations.
Profitability and Efficiency Metrics
Profitability metrics for Vishnu Chemicals Ltd reveal a mixed but generally positive performance. The operating profit margin (OPM) stood at 16% for FY 2025, slightly lower than the 17% recorded in FY 2023. This decline could indicate rising costs or pricing pressures, which are prevalent in the chemicals sector. Net profit for FY 2025 was reported at ₹127 Cr, down from ₹137 Cr the previous year, leading to an earnings per share (EPS) of ₹18.81. Despite this dip, the return on equity (ROE) remains relatively strong at 15.5%, suggesting efficient use of shareholder funds. The interest coverage ratio of 6.53x indicates that the company is comfortably managing its interest obligations, a positive sign for financial stability. Overall, while profitability has faced some challenges, Vishnu Chemicals appears capable of sustaining healthy returns on investment.
Balance Sheet Strength and Financial Ratios
Vishnu Chemicals Ltd’s balance sheet reveals a generally healthy financial position, with total assets recorded at ₹1,635 Cr against borrowings of ₹418 Cr. This results in a manageable debt-to-equity ratio of approximately 0.36x, indicating that the company is not overly reliant on debt financing. The reserves have grown significantly, reaching ₹987 Cr, which offers a cushion for future investments or downturns. The current ratio of 1.70x suggests that the company has sufficient liquidity to meet its short-term obligations. However, the cash conversion cycle (CCC) of 145 days is on the higher side, which could indicate inefficiencies in working capital management. This factor may warrant closer scrutiny from investors as it could impact cash flow in the long term. Overall, while the balance sheet appears solid, the efficiency metrics suggest room for improvement.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vishnu Chemicals Ltd indicates a stable base of investor confidence, with promoters holding 69.21% of the company. This significant stake reflects a strong commitment from the founding family, which is often viewed positively by retail investors. Foreign institutional investors (FIIs) have gradually increased their stake to 2.23%, while domestic institutional investors (DIIs) hold 5.59%. The public shareholding stands at 22.97%, indicating a healthy distribution of shares. The number of shareholders has grown to 31,754, suggesting rising interest in the stock. However, the gradual decline in promoter shareholding from 75% in early 2023 to the current level may raise questions about long-term commitment. Overall, while the shareholding structure is encouraging, the dynamics of promoter ownership could influence investor sentiment moving forward.
Outlook, Risks, and Final Insight
Looking ahead, Vishnu Chemicals faces both opportunities and challenges. The ongoing volatility in raw material prices, coupled with global supply chain disruptions, poses a risk that could impact profitability. Additionally, the company’s relatively high cash conversion cycle may hinder cash flow and operational agility. On the upside, the consistent growth in reserves and a strong interest coverage ratio provide a solid foundation for future expansion. Investors might consider the potential for growth in the chemicals sector, particularly in specialty applications, as a positive indicator. However, they should remain vigilant about market conditions and operational efficiencies. In summary, while Vishnu Chemicals has demonstrated resilience and growth, careful attention to operational metrics and market dynamics will be crucial for sustained investor confidence and stock performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,715 Cr. | 41.9 | 125/40.8 | 135 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 14.5 Cr. | 28.9 | 47.2/25.8 | 62.9 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 204 Cr. | 261 | 402/238 | 12.2 | 211 | 3.07 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,135 Cr. | 497 | 728/408 | 29.9 | 157 | 0.60 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 328 Cr. | 420 | 536/376 | 16.0 | 144 | 0.71 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,725.00 Cr | 550.83 | 167.51 | 160.00 | 0.51% | 13.95% | 10.65% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 359 | 371 | 325 | 336 | 301 | 308 | 304 | 300 | 339 | 344 | 371 | 393 | 347 |
| Expenses | 301 | 312 | 273 | 275 | 250 | 262 | 263 | 237 | 283 | 299 | 308 | 329 | 291 |
| Operating Profit | 58 | 59 | 52 | 61 | 51 | 46 | 41 | 64 | 56 | 45 | 64 | 64 | 56 |
| OPM % | 16% | 16% | 16% | 18% | 17% | 15% | 13% | 21% | 16% | 13% | 17% | 16% | 16% |
| Other Income | 2 | 4 | 6 | 3 | 2 | 3 | 4 | 3 | 3 | 4 | 3 | 6 | 5 |
| Interest | 7 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 8 | 8 |
| Depreciation | 7 | 7 | 7 | 7 | 7 | 9 | 9 | 9 | 9 | 9 | 12 | 8 | 10 |
| Profit before tax | 47 | 48 | 42 | 49 | 37 | 31 | 27 | 49 | 40 | 30 | 44 | 53 | 42 |
| Tax % | 27% | 27% | 25% | 27% | 23% | 22% | 23% | 43% | 24% | 25% | 23% | 27% | 23% |
| Net Profit | 34 | 35 | 32 | 36 | 29 | 24 | 21 | 28 | 30 | 23 | 34 | 39 | 32 |
| EPS in Rs | 5.71 | 5.88 | 5.32 | 5.97 | 4.79 | 3.66 | 3.17 | 4.23 | 4.65 | 3.49 | 5.25 | 5.78 | 4.79 |
Last Updated: August 20, 2025, 1:20 am
Below is a detailed analysis of the quarterly data for Vishnu Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 347.00 Cr.. The value appears to be declining and may need further review. It has decreased from 393.00 Cr. (Mar 2025) to 347.00 Cr., marking a decrease of 46.00 Cr..
- For Expenses, as of Jun 2025, the value is 291.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 329.00 Cr. (Mar 2025) to 291.00 Cr., marking a decrease of 38.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 56.00 Cr.. The value appears to be declining and may need further review. It has decreased from 64.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 8.00 Cr..
- For OPM %, as of Jun 2025, the value is 16.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00%.
- For Other Income, as of Jun 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Depreciation, as of Jun 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 42.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Mar 2025) to 42.00 Cr., marking a decrease of 11.00 Cr..
- For Tax %, as of Jun 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 23.00%, marking a decrease of 4.00%.
- For Net Profit, as of Jun 2025, the value is 32.00 Cr.. The value appears to be declining and may need further review. It has decreased from 39.00 Cr. (Mar 2025) to 32.00 Cr., marking a decrease of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 4.79. The value appears to be declining and may need further review. It has decreased from 5.78 (Mar 2025) to 4.79, marking a decrease of 0.99.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:24 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 418 | 480 | 507 | 643 | 769 | 674 | 679 | 1,069 | 1,391 | 1,213 | 1,447 | 1,512 |
| Expenses | 339 | 396 | 441 | 562 | 667 | 591 | 600 | 911 | 1,160 | 1,010 | 1,217 | 1,270 |
| Operating Profit | 79 | 84 | 66 | 81 | 102 | 82 | 79 | 158 | 231 | 202 | 229 | 241 |
| OPM % | 19% | 18% | 13% | 13% | 13% | 12% | 12% | 15% | 17% | 17% | 16% | 16% |
| Other Income | 1 | 2 | 7 | 8 | 3 | 7 | 3 | 6 | 15 | 12 | 15 | 23 |
| Interest | 34 | 37 | 44 | 49 | 47 | 39 | 27 | 28 | 35 | 37 | 38 | 39 |
| Depreciation | 12 | 13 | 16 | 19 | 21 | 20 | 20 | 23 | 26 | 34 | 38 | 40 |
| Profit before tax | 34 | 36 | 14 | 22 | 37 | 30 | 34 | 112 | 185 | 144 | 168 | 185 |
| Tax % | 36% | 41% | 52% | 35% | 35% | 27% | -1% | 28% | 26% | 30% | 25% | |
| Net Profit | 22 | 21 | 7 | 14 | 24 | 22 | 34 | 81 | 137 | 101 | 127 | 138 |
| EPS in Rs | 3.66 | 3.56 | 1.10 | 2.42 | 4.08 | 3.72 | 5.78 | 13.63 | 22.86 | 15.43 | 18.81 | 20.70 |
| Dividend Payout % | 11% | 6% | 0% | 8% | 5% | 5% | 3% | 3% | 2% | 2% | 2% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -4.55% | -66.67% | 100.00% | 71.43% | -8.33% | 54.55% | 138.24% | 69.14% | -26.28% | 25.74% |
| Change in YoY Net Profit Growth (%) | 0.00% | -62.12% | 166.67% | -28.57% | -79.76% | 62.88% | 83.69% | -69.10% | -95.41% | 52.02% |
Vishnu Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 17% |
| 3 Years: | 11% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 42% |
| 3 Years: | 16% |
| TTM: | 25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 75% |
| 3 Years: | 6% |
| 1 Year: | 19% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 22% |
| 3 Years: | 21% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:51 pm
Balance Sheet
Last Updated: December 4, 2025, 2:12 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 13 | 13 | 13 |
| Reserves | 79 | 106 | 85 | 99 | 130 | 148 | 184 | 265 | 402 | 688 | 913 | 987 |
| Borrowings | 225 | 263 | 322 | 381 | 348 | 328 | 336 | 365 | 379 | 315 | 342 | 418 |
| Other Liabilities | 177 | 239 | 275 | 289 | 266 | 247 | 242 | 274 | 258 | 310 | 366 | 409 |
| Total Liabilities | 492 | 620 | 694 | 782 | 757 | 736 | 773 | 916 | 1,052 | 1,326 | 1,635 | 1,827 |
| Fixed Assets | 186 | 202 | 290 | 349 | 350 | 338 | 387 | 463 | 465 | 635 | 702 | 778 |
| CWIP | 44 | 66 | 62 | 17 | 19 | 36 | 24 | 5 | 98 | 16 | 69 | 56 |
| Investments | 0 | 0 | 1 | 2 | 1 | 1 | 1 | 3 | 2 | 2 | 0 | 0 |
| Other Assets | 262 | 352 | 342 | 415 | 387 | 360 | 361 | 444 | 488 | 675 | 864 | 993 |
| Total Assets | 492 | 620 | 694 | 782 | 757 | 736 | 773 | 916 | 1,052 | 1,326 | 1,635 | 1,827 |
Below is a detailed analysis of the balance sheet data for Vishnu Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 987.00 Cr.. The value appears strong and on an upward trend. It has increased from 913.00 Cr. (Mar 2025) to 987.00 Cr., marking an increase of 74.00 Cr..
- For Borrowings, as of Sep 2025, the value is 418.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 342.00 Cr. (Mar 2025) to 418.00 Cr., marking an increase of 76.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 409.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 366.00 Cr. (Mar 2025) to 409.00 Cr., marking an increase of 43.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,827.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,635.00 Cr. (Mar 2025) to 1,827.00 Cr., marking an increase of 192.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 778.00 Cr.. The value appears strong and on an upward trend. It has increased from 702.00 Cr. (Mar 2025) to 778.00 Cr., marking an increase of 76.00 Cr..
- For CWIP, as of Sep 2025, the value is 56.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 993.00 Cr.. The value appears strong and on an upward trend. It has increased from 864.00 Cr. (Mar 2025) to 993.00 Cr., marking an increase of 129.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,827.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,635.00 Cr. (Mar 2025) to 1,827.00 Cr., marking an increase of 192.00 Cr..
Notably, the Reserves (987.00 Cr.) exceed the Borrowings (418.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -146.00 | -179.00 | -256.00 | -300.00 | -246.00 | -246.00 | -257.00 | -207.00 | -148.00 | -113.00 | -113.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 78 | 88 | 69 | 82 | 64 | 49 | 62 | 65 | 47 | 69 | 74 |
| Inventory Days | 230 | 314 | 269 | 212 | 201 | 252 | 243 | 143 | 142 | 263 | 242 |
| Days Payable | 117 | 225 | 201 | 207 | 147 | 167 | 174 | 146 | 120 | 187 | 172 |
| Cash Conversion Cycle | 191 | 176 | 137 | 87 | 117 | 134 | 131 | 63 | 69 | 145 | 145 |
| Working Capital Days | 37 | 3 | -70 | -24 | -3 | 2 | 6 | 10 | 21 | 54 | 67 |
| ROCE % | 21% | 14% | 16% | 17% | 14% | 12% | 24% | 30% | 20% | 18% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Franklin India Small Cap Fund | 1,659,420 | 0.65 | 87.34 | N/A | N/A | N/A |
| Bandhan Small Cap Fund | 961,765 | 0.28 | 50.62 | 652,741 | 2025-11-03 14:33:44 | 47.34% |
| ITI Multi Cap Fund | 298,690 | 1.17 | 15.72 | 290,199 | 2025-12-15 07:00:15 | 2.93% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 19.23 | 15.90 | 22.86 | 68.13 | 28.88 |
| Diluted EPS (Rs.) | 19.23 | 15.90 | 22.86 | 68.13 | 28.88 |
| Cash EPS (Rs.) | 24.48 | 20.55 | 27.29 | 87.37 | 45.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 137.67 | 107.00 | 69.37 | 231.77 | 164.19 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 137.67 | 107.00 | 69.37 | 231.77 | 164.19 |
| Revenue From Operations / Share (Rs.) | 214.89 | 185.05 | 232.88 | 894.86 | 568.12 |
| PBDIT / Share (Rs.) | 36.20 | 32.66 | 41.07 | 135.12 | 67.19 |
| PBIT / Share (Rs.) | 30.53 | 27.54 | 36.63 | 115.88 | 50.20 |
| PBT / Share (Rs.) | 24.99 | 21.94 | 31.05 | 94.03 | 28.46 |
| Net Profit / Share (Rs.) | 18.81 | 15.43 | 22.86 | 68.13 | 28.88 |
| NP After MI And SOA / Share (Rs.) | 18.81 | 15.43 | 22.86 | 68.13 | 28.88 |
| PBDIT Margin (%) | 16.84 | 17.64 | 17.63 | 15.09 | 11.82 |
| PBIT Margin (%) | 14.20 | 14.88 | 15.73 | 12.94 | 8.83 |
| PBT Margin (%) | 11.62 | 11.85 | 13.33 | 10.50 | 5.01 |
| Net Profit Margin (%) | 8.75 | 8.33 | 9.81 | 7.61 | 5.08 |
| NP After MI And SOA Margin (%) | 8.75 | 8.33 | 9.81 | 7.61 | 5.08 |
| Return on Networth / Equity (%) | 13.66 | 14.41 | 32.95 | 29.39 | 17.58 |
| Return on Capital Employeed (%) | 17.99 | 19.84 | 31.99 | 25.40 | 13.47 |
| Return On Assets (%) | 7.75 | 7.62 | 12.99 | 8.89 | 4.46 |
| Long Term Debt / Equity (X) | 0.17 | 0.11 | 0.34 | 0.46 | 0.50 |
| Total Debt / Equity (X) | 0.36 | 0.34 | 0.72 | 1.04 | 1.17 |
| Asset Turnover Ratio (%) | 0.97 | 1.02 | 1.40 | 1.18 | 0.78 |
| Current Ratio (X) | 1.70 | 1.58 | 1.28 | 1.13 | 1.06 |
| Quick Ratio (X) | 0.88 | 0.81 | 0.71 | 0.67 | 0.48 |
| Inventory Turnover Ratio (X) | 4.02 | 2.69 | 3.89 | 2.86 | 1.60 |
| Dividend Payout Ratio (NP) (%) | 1.55 | 2.59 | 1.74 | 1.46 | 3.46 |
| Dividend Payout Ratio (CP) (%) | 1.19 | 1.94 | 1.46 | 1.14 | 2.18 |
| Earning Retention Ratio (%) | 98.45 | 97.41 | 98.26 | 98.54 | 96.54 |
| Cash Earning Retention Ratio (%) | 98.81 | 98.06 | 98.54 | 98.86 | 97.82 |
| Interest Coverage Ratio (X) | 6.53 | 5.83 | 7.35 | 6.19 | 3.09 |
| Interest Coverage Ratio (Post Tax) (X) | 4.40 | 3.75 | 5.09 | 4.12 | 2.33 |
| Enterprise Value (Cr.) | 3341.23 | 2341.14 | 1974.14 | 2250.42 | 636.06 |
| EV / Net Operating Revenue (X) | 2.31 | 1.93 | 1.42 | 2.11 | 0.93 |
| EV / EBITDA (X) | 13.71 | 10.94 | 8.05 | 13.94 | 7.92 |
| MarketCap / Net Operating Revenue (X) | 2.13 | 1.72 | 1.16 | 1.78 | 0.50 |
| Retention Ratios (%) | 98.44 | 97.40 | 98.25 | 98.53 | 96.53 |
| Price / BV (X) | 3.32 | 2.98 | 3.90 | 6.87 | 1.74 |
| Price / Net Operating Revenue (X) | 2.13 | 1.72 | 1.16 | 1.78 | 0.50 |
| EarningsYield | 0.04 | 0.04 | 0.08 | 0.04 | 0.10 |
After reviewing the key financial ratios for Vishnu Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 19.23. This value is within the healthy range. It has increased from 15.90 (Mar 24) to 19.23, marking an increase of 3.33.
- For Diluted EPS (Rs.), as of Mar 25, the value is 19.23. This value is within the healthy range. It has increased from 15.90 (Mar 24) to 19.23, marking an increase of 3.33.
- For Cash EPS (Rs.), as of Mar 25, the value is 24.48. This value is within the healthy range. It has increased from 20.55 (Mar 24) to 24.48, marking an increase of 3.93.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 137.67. It has increased from 107.00 (Mar 24) to 137.67, marking an increase of 30.67.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 137.67. It has increased from 107.00 (Mar 24) to 137.67, marking an increase of 30.67.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 214.89. It has increased from 185.05 (Mar 24) to 214.89, marking an increase of 29.84.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 36.20. This value is within the healthy range. It has increased from 32.66 (Mar 24) to 36.20, marking an increase of 3.54.
- For PBIT / Share (Rs.), as of Mar 25, the value is 30.53. This value is within the healthy range. It has increased from 27.54 (Mar 24) to 30.53, marking an increase of 2.99.
- For PBT / Share (Rs.), as of Mar 25, the value is 24.99. This value is within the healthy range. It has increased from 21.94 (Mar 24) to 24.99, marking an increase of 3.05.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 18.81. This value is within the healthy range. It has increased from 15.43 (Mar 24) to 18.81, marking an increase of 3.38.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 18.81. This value is within the healthy range. It has increased from 15.43 (Mar 24) to 18.81, marking an increase of 3.38.
- For PBDIT Margin (%), as of Mar 25, the value is 16.84. This value is within the healthy range. It has decreased from 17.64 (Mar 24) to 16.84, marking a decrease of 0.80.
- For PBIT Margin (%), as of Mar 25, the value is 14.20. This value is within the healthy range. It has decreased from 14.88 (Mar 24) to 14.20, marking a decrease of 0.68.
- For PBT Margin (%), as of Mar 25, the value is 11.62. This value is within the healthy range. It has decreased from 11.85 (Mar 24) to 11.62, marking a decrease of 0.23.
- For Net Profit Margin (%), as of Mar 25, the value is 8.75. This value is within the healthy range. It has increased from 8.33 (Mar 24) to 8.75, marking an increase of 0.42.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.75. This value is within the healthy range. It has increased from 8.33 (Mar 24) to 8.75, marking an increase of 0.42.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.66. This value is below the healthy minimum of 15. It has decreased from 14.41 (Mar 24) to 13.66, marking a decrease of 0.75.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.99. This value is within the healthy range. It has decreased from 19.84 (Mar 24) to 17.99, marking a decrease of 1.85.
- For Return On Assets (%), as of Mar 25, the value is 7.75. This value is within the healthy range. It has increased from 7.62 (Mar 24) to 7.75, marking an increase of 0.13.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 0.2. It has increased from 0.11 (Mar 24) to 0.17, marking an increase of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.36. This value is within the healthy range. It has increased from 0.34 (Mar 24) to 0.36, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.97. It has decreased from 1.02 (Mar 24) to 0.97, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 1.70, marking an increase of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has increased from 0.81 (Mar 24) to 0.88, marking an increase of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.02. This value is within the healthy range. It has increased from 2.69 (Mar 24) to 4.02, marking an increase of 1.33.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 1.55. This value is below the healthy minimum of 20. It has decreased from 2.59 (Mar 24) to 1.55, marking a decrease of 1.04.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 20. It has decreased from 1.94 (Mar 24) to 1.19, marking a decrease of 0.75.
- For Earning Retention Ratio (%), as of Mar 25, the value is 98.45. This value exceeds the healthy maximum of 70. It has increased from 97.41 (Mar 24) to 98.45, marking an increase of 1.04.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 98.81. This value exceeds the healthy maximum of 70. It has increased from 98.06 (Mar 24) to 98.81, marking an increase of 0.75.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.53. This value is within the healthy range. It has increased from 5.83 (Mar 24) to 6.53, marking an increase of 0.70.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.40. This value is within the healthy range. It has increased from 3.75 (Mar 24) to 4.40, marking an increase of 0.65.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,341.23. It has increased from 2,341.14 (Mar 24) to 3,341.23, marking an increase of 1,000.09.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 1.93 (Mar 24) to 2.31, marking an increase of 0.38.
- For EV / EBITDA (X), as of Mar 25, the value is 13.71. This value is within the healthy range. It has increased from 10.94 (Mar 24) to 13.71, marking an increase of 2.77.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.13. This value is within the healthy range. It has increased from 1.72 (Mar 24) to 2.13, marking an increase of 0.41.
- For Retention Ratios (%), as of Mar 25, the value is 98.44. This value exceeds the healthy maximum of 70. It has increased from 97.40 (Mar 24) to 98.44, marking an increase of 1.04.
- For Price / BV (X), as of Mar 25, the value is 3.32. This value exceeds the healthy maximum of 3. It has increased from 2.98 (Mar 24) to 3.32, marking an increase of 0.34.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.13. This value is within the healthy range. It has increased from 1.72 (Mar 24) to 2.13, marking an increase of 0.41.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vishnu Chemicals Ltd:
- Net Profit Margin: 8.75%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.99% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.66% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.4
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.88
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25.2 (Industry average Stock P/E: 167.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.36
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.75%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | Plot No. C-23, Road No. 8, Film Nagar, Jubilee Hills, Hyderabad Telangana 500096 | vishnu@vishnuchemicals.com http://www.vishnuchemicals.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Cherukuri Krishna Murthy | Chairman & Managing Director |
| Mr. Cherukuri Siddartha | Joint Managing Director |
| Mrs. Cherukuri Manjula | Non Executive Director |
| Mr. Tirthankar Mitra | Independent Director |
| Mr. Naga Bhushan Bhagwat | Independent Director |
| Mr. Veeramachaneni Vimalanand | Independent Director |
| Dr. Sita Vanka | Independent Director |
FAQ
What is the intrinsic value of Vishnu Chemicals Ltd?
Vishnu Chemicals Ltd's intrinsic value (as of 18 December 2025) is 465.87 which is 9.72% lower the current market price of 516.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,488 Cr. market cap, FY2025-2026 high/low of 596/336, reserves of ₹987 Cr, and liabilities of 1,827 Cr.
What is the Market Cap of Vishnu Chemicals Ltd?
The Market Cap of Vishnu Chemicals Ltd is 3,488 Cr..
What is the current Stock Price of Vishnu Chemicals Ltd as on 18 December 2025?
The current stock price of Vishnu Chemicals Ltd as on 18 December 2025 is 516.
What is the High / Low of Vishnu Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vishnu Chemicals Ltd stocks is 596/336.
What is the Stock P/E of Vishnu Chemicals Ltd?
The Stock P/E of Vishnu Chemicals Ltd is 25.2.
What is the Book Value of Vishnu Chemicals Ltd?
The Book Value of Vishnu Chemicals Ltd is 149.
What is the Dividend Yield of Vishnu Chemicals Ltd?
The Dividend Yield of Vishnu Chemicals Ltd is 0.06 %.
What is the ROCE of Vishnu Chemicals Ltd?
The ROCE of Vishnu Chemicals Ltd is 18.1 %.
What is the ROE of Vishnu Chemicals Ltd?
The ROE of Vishnu Chemicals Ltd is 15.5 %.
What is the Face Value of Vishnu Chemicals Ltd?
The Face Value of Vishnu Chemicals Ltd is 2.00.